Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
Status:
Terminated
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how genes influence the response to mycophenolate
mofetil (CellCept) in children who have had a kidney transplant. The study will look at how
differences in some genes effect blood levels of mycophenolate mofetil over time in children,
how often side effects occur and the way that children respond to mycophenolate mofetil.
The results may lead to better dosing based on individual needs.